Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001595585-20-000066
Filing Date
2020-05-08
Accepted
2020-05-08 16:17:50
Documents
61
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tcda-20200331.htm   iXBRL 10-Q 1686467
2 EX-10.2 exhibit102fourthamendt.htm EX-10.2 67142
3 EX-31.1 exhibit311ceo302certif.htm EX-31.1 11349
4 EX-31.2 exhibit312cfo302certif.htm EX-31.2 11384
5 EX-32.1 exhibit321ceoandcfo906.htm EX-32.1 9526
11 image01.jpg GRAPHIC 762
12 image11.jpg GRAPHIC 807
  Complete submission text file 0001595585-20-000066.txt   6546163

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20200331.xsd EX-101.SCH 41118
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcda-20200331_cal.xml EX-101.CAL 77690
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcda-20200331_def.xml EX-101.DEF 182994
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20200331_lab.xml EX-101.LAB 500522
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20200331_pre.xml EX-101.PRE 312914
26 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20200331_htm.xml XML 1111757
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

EIN.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38558 | Film No.: 20860795
SIC: 2834 Pharmaceutical Preparations